Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1258855 10.3389/fphar.2023.1258855 Pharmacology Correction Corrigendum: A Chinese medicine formula (Bushen Huoxue Tongluo) for the treatment of chronic subjective tinnitus: a study protocol for a pilot, assessor-blinded, randomized clinical trial Zhang et al. 10.3389/fphar.2023.1258855 Zhang Hong Wei 1 2 * Yeung Kammy N. K. 3 Tong Michael C. F. 3 Lin Zhi-Xiu 1 2 Chang Waitsz W. T. 3 Ng Iris H-Y. 3 Sum Chi Him 2 Leung Ka Chun 2 Chan Kam Leung 1 2 Ngan Kit 4 Tong Tie Jun 5 1 Faculty of Medicine, School of Chinese Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China 2 Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China 3 Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China 4 Prime & Naturals Clinic, Hong Kong, Hong Kong SAR, China 5 Department of Mathematics, Hong Kong Baptist University, Hong Kong, Hong Kong SAR, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Hong Wei Zhang, zhanghw@cuhk.edu.hk 07 09 2023 2023 14 1258855 14 07 2023 17 07 2023 Copyright © 2023 Zhang, Yeung, Tong, Lin, Chang, Ng, Sum, Leung, Chan, Ngan and Tong. 2023 Zhang, Yeung, Tong, Lin, Chang, Ng, Sum, Leung, Chan, Ngan and Tong

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on A Chinese medicine formula (Bushen Huoxue Tongluo) for the treatment of chronic subjective tinnitus: a study protocol for a pilot, assessor-blinded, randomized clinical trial by Zhang HW, Yeung KNK, Tong MCF, Lin Z-, Chang WWT, Ng IH-, Sum CH, Leung KC, Chan KL, Ngan K and Tong TJ (2022). Front. Pharmacol. 13:844730. doi: 10.3389/fphar. 2022.844730 Chinese medicine tinnitus randomized controlled trial pilot clinical trial protocol herb section-at-acceptance Ethnopharmacology

In the published article, there was an error in the Funding statement. This study is supported by Health and Medical Research Fund (HMRF), Food and Health Bureau, Hong Kong, China (No. 18190691).The correct Funding statement appears below.

“This study is supported by Health and Medical Research Fund (HMRF), Food and Health Bureau, Hong Kong, China (No. 17180941)”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.